UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029783
Receipt number R000034030
Scientific Title Pain thresholds induced by transcranial magnetic stimulation to the head
Date of disclosure of the study information 2017/11/01
Last modified on 2021/02/17 11:26:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pain thresholds induced by transcranial magnetic stimulation to the head

Acronym

Pain thresholds induced by transcranial magnetic stimulation to the head

Scientific Title

Pain thresholds induced by transcranial magnetic stimulation to the head

Scientific Title:Acronym

Pain thresholds induced by transcranial magnetic stimulation to the head

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of the study is to examine pain thresholds induced by transcranial magnetic stimulation to the head.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pain threshold

Key secondary outcomes

perceptual threshold
head structural MRI


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Transcranial magnetic stimulation to the head

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Individuals without a neurological or psychiatric history
2. Capability of informed consent based on their own decision

Key exclusion criteria

1. Individuals with a history of head trauma
2. Individuals with a history of organic brain disease
3. Individuals with a history or current history of substance dependence
4. Individuals who are taking central nervous system stimulants
5. Individuals who have a history of disorders of consciousness and/or seizure
6. Individuals who have a chronic headache
7. Individuals who are unable to undergo MRI
8. Individuals who are unable to undergo TMS
9. Individuals that researchers decide that they are inappropriate for study participation.

Target sample size

89


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Tanaka

Organization

Hamamatsu University School of Medicine

Division name

Psychology

Zip code

431-3192

Address

1-20-1 Handayama Higashi-ku, Hamamatsu-city, Japan

TEL

053-453-2111

Email

tanakas@hama-med.ac.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Tanaka

Organization

Hamamatsu University School of Medicine

Division name

Psychology

Zip code

431-3192

Address

1-20-1 Handayama Higashi-ku, Hamamatsu-city, Japan

TEL

053-453-2111

Homepage URL


Email

tanakas@hama-med.ac.jp


Sponsor or person

Institute

Hamamatsu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Internal Affairs and Communications.

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Nagoya Institute of Technology

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hamamatsu University School of Medicine

Address

1-20-1 Handayama Higashi-ku, Hamamatsu-city, Japan

Tel

053-453-2111

Email

tanakas@hama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

浜松医科大学(静岡県)
Hamamatsu University School of Medicine (Shizuoka)


Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 06 Day

Date of IRB

2017 Year 10 Month 06 Day

Anticipated trial start date

2017 Year 11 Month 01 Day

Last follow-up date

2021 Year 02 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 11 Month 01 Day

Last modified on

2021 Year 02 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034030


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name